- WorkersStops taxpayer dollars from directly supporting animal experimentation in specified adversarial-country laboratories.
- WorkersReduces risks of inadvertent transfer of technologies or biological materials through animal testing collaborations.
- Potential benefitReinforces national security by restricting research ties with countries identified as concerns.
Accountability in Foreign Animal Research Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Prohibits the Department of Health and Human Services from conducting or funding biomedical research that tests on vertebrate animals in facilities located in, or owned or controlled by, specified foreign countries (China including Hong Kong, Iran, North Korea, and Russia) or any other country the Secretary designates in consultation with State and Defense. Bars HHS support via grants, contracts, or other funding vehicles for such foreign-based animal testing.
Security vs. scientific collaboration: national-security focus clashes with global research needs
Relative to its intended legislative type, this bill establishes a targeted prohibition on HHS-funded animal experimentation tied to specified foreign countries and a consultative reporting process for adding others.
Prohibits the Department of Health and Human Services from conducting or funding biomedical research that tests on vertebrate animals in facilities located in, or owned or controlled by, specified foreign countries (China including Hong Kong, Iran, North Korea, and Russia) or any other country the Secretary designates in consultation with State and Defense.
Bars HHS support via grants, contracts, or other funding vehicles for such foreign-based animal testing.
Requires HHS to report to specific congressional committees within 60 days whenever it designates an additional country, explaining the reasoning.
Narrow, security-framed restriction increases viability, but research community concerns and higher-chamber consensus requirements reduce overall odds.
Relative to its intended legislative type, this bill establishes a targeted prohibition on HHS-funded animal experimentation tied to specified foreign countries and a consultative reporting process for adding others. It names the implementing officer and the committees to receive reports, but omits several implementation details commonly expected for a funding restriction.
Security vs. scientific collaboration: national-security focus clashes with global research needs
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- WorkersLimits international scientific collaboration, which could slow some biomedical research advances.
- Potential burdenComplicates multinational studies using vertebrate models, potentially delaying projects or excluding partners.
- Potential burdenImposes administrative screening burdens on HHS and grant recipients to ensure compliance.
Why the argument around this bill splits.
Security vs. scientific collaboration: national-security focus clashes with global research needs
Generally supportive of preventing taxpayer dollars from aiding adversarial regimes, but wary of collateral harm to global public-health science and animal welfare oversight.
Concerned about impacts on pandemic research, multinational collaborations, and transparency in how designations are made.
Might press for narrow, public-health-preserving exceptions and strong oversight.
Sees the bill as a reasonable national-security precaution but notes vagueness and potential administrative burden.
Wants clearer definitions, targeted scope, and safeguards to avoid unintended disruption of legitimate research and emergency cooperation.
Likely to weigh benefits against practical implementation costs.
Likely strongly supportive as a national-security and accountability measure to prevent U.S. taxpayer funds from benefiting adversarial regimes.
May argue for expanding scope and enforcement and favor no broad exemptions.
Views reporting requirements as a minimal oversight step.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, security-framed restriction increases viability, but research community concerns and higher-chamber consensus requirements reduce overall odds.
- No formal cost estimate or agency compliance analysis included
- Vague definition and scope of "owned or controlled" foreign facilities
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Security vs. scientific collaboration: national-security focus clashes with global research needs
Narrow, security-framed restriction increases viability, but research community concerns and higher-chamber consensus requirements reduce o…
Relative to its intended legislative type, this bill establishes a targeted prohibition on HHS-funded animal experimentation tied to specified foreign countries and a consultative reporting process for adding others. It…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.